• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 病毒载量对 2019 年冠状病毒病住院患者插管和死亡率风险的影响。

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019.

机构信息

NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, USA.

Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

出版信息

Clin Infect Dis. 2021 Dec 6;73(11):e4197-e4205. doi: 10.1093/cid/ciaa851.

DOI:10.1093/cid/ciaa851
PMID:32603425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7337625/
Abstract

BACKGROUND

Patients hospitalized with coronavirus disease 2019 (COVID-19) frequently require mechanical ventilation and have high mortality rates. However, the impact of viral burden on these outcomes is unknown.

METHODS

We conducted a retrospective cohort study of patients hospitalized with COVID-19 from 30 March 2020 to 30 April 2020 at 2 hospitals in New York City. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load was assessed using cycle threshold (Ct) values from a reverse transcription-polymerase chain reaction assay applied to nasopharyngeal swab samples. We compared characteristics and outcomes of patients with high, medium, and low admission viral loads and assessed whether viral load was independently associated with intubation and in-hospital mortality.

RESULTS

We evaluated 678 patients with COVID-19. Higher viral load was associated with increased age, comorbidities, smoking status, and recent chemotherapy. In-hospital mortality was 35.0% (Ct <25; n = 220), 17.6% (Ct 25-30; n = 216), and 6.2% (Ct >30; n = 242) with high, medium, and low viral loads, respectively (P < .001). The risk of intubation was also higher in patients with a high viral load (29.1%) compared with those with a medium (20.8%) or low viral load (14.9%; P < .001). High viral load was independently associated with mortality (adjusted odds ratio [aOR], 6.05; 95% confidence interval [CI], 2.92-12.52) and intubation (aOR, 2.73; 95% CI, 1.68-4.44).

CONCLUSIONS

Admission SARS-CoV-2 viral load among hospitalized patients with COVID-19 independently correlates with the risk of intubation and in-hospital mortality. Providing this information to clinicians could potentially be used to guide patient care.

摘要

背景

患有 2019 年冠状病毒病(COVID-19)的患者经常需要接受机械通气,死亡率很高。但是,病毒负担对这些结果的影响尚不清楚。

方法

我们对 2020 年 3 月 30 日至 4 月 30 日期间在纽约市 2 家医院住院的 COVID-19 患者进行了回顾性队列研究。使用逆转录-聚合酶链反应(RT-PCR)检测鼻咽拭子样本中的 Ct 值来评估严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)病毒载量。我们比较了高、中、低入院病毒载量患者的特征和结局,并评估了病毒载量是否与插管和住院死亡率独立相关。

结果

我们评估了 678 例 COVID-19 患者。较高的病毒载量与年龄较大、合并症、吸烟状况和近期化疗有关。住院死亡率分别为 35.0%(Ct 值<25;n=220)、17.6%(Ct 值 25-30;n=216)和 6.2%(Ct 值>30;n=242),高、中、低病毒载量组之间的死亡率差异具有统计学意义(P<0.001)。高病毒载量组患者插管的风险也高于中病毒载量组(29.1%比 20.8%;P<0.001)和低病毒载量组(14.9%)。高病毒载量与死亡率(校正比值比[aOR],6.05;95%置信区间[CI],2.92-12.52)和插管(aOR,2.73;95% CI,1.68-4.44)独立相关。

结论

COVID-19 住院患者入院时的 SARS-CoV-2 病毒载量与插管和住院死亡率的风险独立相关。向临床医生提供这些信息可能有助于指导患者治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb28/8662773/ad2e12177f71/ciaa851f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb28/8662773/d7f671abd7ee/ciaa851f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb28/8662773/19a62406fe23/ciaa851f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb28/8662773/ad2e12177f71/ciaa851f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb28/8662773/d7f671abd7ee/ciaa851f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb28/8662773/19a62406fe23/ciaa851f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb28/8662773/ad2e12177f71/ciaa851f0003.jpg

相似文献

1
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019.严重急性呼吸综合征冠状病毒 2 病毒载量对 2019 年冠状病毒病住院患者插管和死亡率风险的影响。
Clin Infect Dis. 2021 Dec 6;73(11):e4197-e4205. doi: 10.1093/cid/ciaa851.
2
The Impact of SARS-CoV-2 Viral Load on the Mortality of Hospitalized Patients: A Retrospective Analysis.严重急性呼吸综合征冠状病毒2型病毒载量对住院患者死亡率的影响:一项回顾性分析
Cureus. 2021 Jul 21;13(7):e16540. doi: 10.7759/cureus.16540. eCollection 2021 Jul.
3
SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19.SARS-CoV-2 病毒载量可预测 COVID-19 住院患者的死亡率,无论其是否患有癌症。
Cancer Cell. 2020 Nov 9;38(5):661-671.e2. doi: 10.1016/j.ccell.2020.09.007. Epub 2020 Sep 15.
4
SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic.严重急性呼吸综合征冠状病毒 2 型感染:初始病毒载量(iVL)可预测疾病严重程度/结局,住院患者 iVL 的下降趋势与大流行的减缓相对应。
PLoS One. 2021 Sep 16;16(9):e0255981. doi: 10.1371/journal.pone.0255981. eCollection 2021.
5
SARS-CoV-2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID-19 severity and mortality.急诊科鼻咽拭子中 SARS-CoV-2 病毒载量不能预测 COVID-19 的严重程度和死亡率。
Acad Emerg Med. 2021 Mar;28(3):306-313. doi: 10.1111/acem.14217. Epub 2021 Feb 5.
6
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
7
Changes in SARS-CoV-2 viral load and mortality during the initial wave of the pandemic in New York City.新冠病毒载量和死亡率在纽约市大流行初期的变化。
PLoS One. 2021 Nov 19;16(11):e0257979. doi: 10.1371/journal.pone.0257979. eCollection 2021.
8
Initial Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load Is Associated With Disease Severity: A Retrospective Cohort Study.初始严重急性呼吸综合征冠状病毒2病毒载量与疾病严重程度相关:一项回顾性队列研究。
Open Forum Infect Dis. 2022 May 1;9(7):ofac223. doi: 10.1093/ofid/ofac223. eCollection 2022 Jul.
9
Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.患有严重或危急 2019 冠状病毒病的孕妇与未怀孕的匹配对照相比,复合发病率增加。
Am J Obstet Gynecol. 2021 May;224(5):510.e1-510.e12. doi: 10.1016/j.ajog.2020.11.022. Epub 2020 Nov 20.
10
Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa.南非免疫功能低下的人类免疫缺陷病毒(HIV)感染者住院患者中高病毒载量下严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的长时间脱落。
Clin Infect Dis. 2022 Aug 24;75(1):e144-e156. doi: 10.1093/cid/ciac077.

引用本文的文献

1
The impact of remdesivir on renal and liver functions in severe COVID-19 patients with presence of viral load.瑞德西韦对病毒载量阳性的重症COVID-19患者肾功能和肝功能的影响。
Sci Rep. 2025 Jul 1;15(1):20900. doi: 10.1038/s41598-025-05541-9.
2
Associations between public health measures and mortality among hospitalised COVID-19 patients: a cross-sectional study in Malaysia.公共卫生措施与住院COVID-19患者死亡率之间的关联:马来西亚的一项横断面研究。
Sci Rep. 2025 Jul 1;15(1):21141. doi: 10.1038/s41598-025-07363-1.
3
Respiratory viruses Ct values and association with clinical outcomes among adults visiting the ED with lower respiratory tract infections.

本文引用的文献

1
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的使用与新型冠状病毒病 2019(COVID-19)检测阳性的关联。
JAMA Cardiol. 2020 Sep 1;5(9):1020-1026. doi: 10.1001/jamacardio.2020.1855.
2
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.纽约 1000 例 2019 年冠状病毒病患者的特征和临床过程:回顾性病例系列研究。
BMJ. 2020 May 29;369:m1996. doi: 10.1136/bmj.m1996.
3
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
患有下呼吸道感染前往急诊科就诊的成年人中呼吸道病毒的Ct值及其与临床结局的关联。
PLoS One. 2025 May 29;20(5):e0320503. doi: 10.1371/journal.pone.0320503. eCollection 2025.
4
Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with lung infection and tissue-damage biomarkers.血浆严重急性呼吸综合征冠状病毒2核衣壳抗原水平与肺部感染及组织损伤生物标志物相关。
Virus Res. 2025 Jun;356:199580. doi: 10.1016/j.virusres.2025.199580. Epub 2025 May 12.
5
The Association Between the Ct Value of SARS-CoV-2 and the Risk of Death from COVID-19 in Amazonas, Peru, During the Circulation of the Lambda, Gamma, and Delta Variants.秘鲁亚马孙地区在 Lambda、Gamma 和 Delta 变异株传播期间,新冠病毒(SARS-CoV-2)的 Ct 值与 COVID-19 死亡风险之间的关联
Viruses. 2025 Apr 12;17(4):558. doi: 10.3390/v17040558.
6
Direct medical cost of adult Covid-19 ınpatients and ıts determinants at a university hospital.某大学医院成人新冠住院患者的直接医疗费用及其影响因素
PLoS One. 2025 Apr 7;20(4):e0319762. doi: 10.1371/journal.pone.0319762. eCollection 2025.
7
Defining the Critical Requisites for Accurate Simulation of SARS-CoV-2 Viral Dynamics: Patient Characteristics and Data Collection Protocol.确定准确模拟SARS-CoV-2病毒动力学的关键要求:患者特征和数据收集方案。
J Med Virol. 2025 Jan;97(1):e70174. doi: 10.1002/jmv.70174.
8
Multicenter Evaluation of the QIAstat-Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens.QIAstat-Dx和BioFire多重检测板检测呼吸道病原体的多中心评估
J Med Virol. 2024 Dec;96(12):e70129. doi: 10.1002/jmv.70129.
9
Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19.新型SARS-CoV-2抗病毒药物伊布扎特雷韦对成人COVID-19患者的病毒学反应及安全性
Clin Infect Dis. 2025 Mar 17;80(3):673-680. doi: 10.1093/cid/ciae529.
10
Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19-Associated Venous Thromboembolism.2019年冠状病毒病(COVID-19)原始单价信使核糖核酸疫苗接种系列预防COVID-19相关静脉血栓栓塞症住院的有效性
J Infect Dis. 2025 Feb 20;231(2):378-385. doi: 10.1093/infdis/jiae502.
《纽约市 COVID-19 重症成人的流行病学、临床病程和结局:一项前瞻性队列研究》
Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19.
4
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.从诊断样本中预测传染性严重急性呼吸综合征冠状病毒 2。
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666. doi: 10.1093/cid/ciaa638.
5
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.Cepheid Xpert Xpress 和 Abbott ID Now 与 Roche cobas 用于 SARS-CoV-2 快速检测的比较。
J Clin Virol. 2020 Jul;128:104428. doi: 10.1016/j.jcv.2020.104428. Epub 2020 May 13.
6
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.瑞德西韦的紧急使用授权:透明分配流程的必要性。
JAMA. 2020 Jun 16;323(23):2365-2366. doi: 10.1001/jama.2020.8863.
7
Multiorgan and Renal Tropism of SARS-CoV-2.新型冠状病毒2019(SARS-CoV-2)的多器官及肾脏嗜性
N Engl J Med. 2020 Aug 6;383(6):590-592. doi: 10.1056/NEJMc2011400. Epub 2020 May 13.
8
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
9
Comparison of Two High-Throughput Reverse Transcription-PCR Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2.两种用于检测严重急性呼吸综合征冠状病毒2的高通量逆转录聚合酶链反应系统的比较
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00890-20.
10
Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 - Georgia, March 2020.《2020 年 3 月佐治亚州因 COVID-19 住院的成年患者的特征和临床结局》。
MMWR Morb Mortal Wkly Rep. 2020 May 8;69(18):545-550. doi: 10.15585/mmwr.mm6918e1.